LARSEN; Christian P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LARSEN; Christian P..The latest application filed is for "anti-cd40 antibodies and uses thereof".

Company Profile

2.8.17

LARSEN; Christian P. - Atlanta GA
Larsen; Christian P. - Alexandria VA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-cd40 Antibodies And Uses Thereof App 20220133887 - REIMANN; Keith A. ; et al.	2022-05-05
Anti-cd40 Antibodies And Uses Thereof App 20200261574 - REIMANN; Keith A. ; et al.	2020-08-20
Methods Of Treating Transplant Rejection Using A Domain Antibody Directed Against Cd40l App 20200231676 - SURI; Anish ; et al.	2020-07-23
Polynucleotides encoding anti-CD40 antibodies Grant 10,561,728 - Reimann , et al. Feb	2020-02-18
Anti-cd40 Antibodies And Uses Thereof App 20180344845 - Reimann; Keith A. ; et al.	2018-12-06
Anti-CD40 antibodies and methods of administering thereof Grant 9,987,356 - Reimann , et al. June 5, 2	2018-06-05
Methods Of Treating Transplant Rejection Using A Domain Antibody Directed Against Cd40 App 20170051059 - SURI; Anish ; et al.	2017-02-23
Use of mTOR Inhibitors to Enhance T Cell Immune Responses App 20160324834 - Ahmed; Rafi R. ; et al.	2016-11-10
USE OF mTOR INHIBITORS TO ENHANCE T CELL IMMUNE RESPONSES App 20140370059 - Ahmed; Rafi R. ; et al.	2014-12-18
Use of mTOR inhibitors to enhance T cell immune responses Grant 8,840,899 - Ahmed , et al. September 23, 2	2014-09-23
Anti-cd40 Antibodies And Uses Thereof App 20140093497 - Reimann; Keith A. ; et al.	2014-04-03
Use of mTOR Inhibitors to Enhance T Cell Immune Responses App 20110129496 - Ahmed; Rafi ; et al.	2011-06-02
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules Grant 7,829,534 - Larsen , et al. November 9, 2	2010-11-09
Methods For Inhibiting An Immune Response By Blocking The Gp39/cd40 And Ctla4/cd28/b7 Pathways And Compositions For Use Therewith App 20090186037 - Larsen; Christian P. ; et al.	2009-07-23
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules App 20080160022 - Larsen; Christian P. ; et al.	2008-07-03
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules Grant 7,304,033 - Larsen , et al. December 4, 2	2007-12-04
Method and system for preventing identity theft and providing credit independent completion of transactions App 20070106611 - Larsen; Christian P.	2007-05-10
Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith App 20050202011 - Larsen, Christian P. ; et al.	2005-09-15
Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules App 20030022836 - Larsen, Christian P. ; et al.	2003-01-30
Methods of inducing organ transplant tolerance and correcting hemoglobinopathies App 20030007968 - Larsen, Christian P. ; et al.	2003-01-09
Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith App 20020031510 - Larsen, Christian P. ; et al.	2002-03-14
Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith Grant 5,916,560 - Larsen , et al. June 29, 1	1999-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.